VS

Vivek Shantilal Langnecha

Active Director Director DIN 11949326
DIN 11949326 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vivek Shantilal Langnecha

Vivek Shantilal Langnecha is a Director at Nexurion Pharma Private Limited (since 2026).

DIN 11949326
Primary Designation Director
First Appointment 16 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nexurion Pharma Private Limited U21000GJ2026PTC183747
Director16 Sep 20262026Active

Directorship timeline

Open interactive timeline →
Nexurion Pharma Private Limited
Premium access

Shareholding and investment profile for Vivek Shantilal Langnecha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Shantilal Langnecha

Vivek Shantilal Langnecha currently holds 1 directorship: Nexurion Pharma Private Limited (Director, since 16 Sep 2026).

Vivek Shantilal Langnecha was first appointed on 16 Sep 2026 as Director at Nexurion Pharma Private Limited.

The current boards of Vivek Shantilal Langnecha's companies include Darshil Anilbhai Kathiriya (Nexurion Pharma Private Limited), Krunal Kirtikumar Shah (Nexurion Pharma Private Limited), Mayur Ashokbhai Kikani (Nexurion Pharma Private Limited), Parth Ramjibhai Savaliya (Nexurion Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available